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Abstract 
The connection between sleep disturbance and mood dysregulation is a current point of interest 
in the field. The circadian rhythm system, which influences both sleep and mood, is itself 
influenced by a variety of internal and external factors, one of which is light. Light manipulation 
is a low-cost, non-invasive possibility for improving sleep and mood disturbances; blocking blue 
wavelengths of light with amber-tinted glasses has been shown to improve sleep quality, energy 
levels and mood. However, methods historically employed in studying sleep and mood are 
limited in that assessments are generally given once per day, and may not give a complete 
picture as to how well these interventions work. The present study used ecological momentary 
assessment (EMA) to assess responsiveness to amber glasses (and blue lensed control glasses) 
four times a day. Using a randomized crossover design, 38 participants at the University of North 
Carolina at Chapel Hill were assigned to starting condition and wore colored glasses three hours 
before bed for 12 of the 18 days of the study. Overall, the results did not support the hypothesis 
that the amber glasses condition would improve sleep quality, energy, and mood: on some 
outcome measures (sleep quality, energy level, positive affect), amber glasses steadily increased 
sleep quality over the course of the condition, but this effect was also seen in the blue glasses 
control condition. Future studies should include a washout period between conditions, a larger, 
more diverse sample, more objective measures of sleep, and other colors of potential control 
lenses.  
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Using Ecological Momentary Assessment (EMA) to Study the Impact of Colored Glasses on 
Sleep Quality, Energy Level, and Mood 
Sleep disturbance and circadian rhythm dysregulation have been linked with a number of 
psychiatric diagnoses, including affective disorders, anxiety disorders, dementia, and 
schizophrenia, as well as other health problems, like cardiovascular disease, cancer, obesity, and 
diabetes (Harvey, Murray, Chandler, & Soehner, 2011; Zelinski, Deibel, & McDonald, 2014).  
This could be due to the interactions between the biochemical pathways associated with rhythm 
generation and those associated with mood, anxiety, and health (Zelinski et al., 2014). Luckily, 
promising cost-effective interventions are being studied to help improve sleep hygiene and 
overall functioning. Light manipulation, in particular, is currently a point of interest in the field, 
as blocking certain wavelengths of light can help improve sleep latency and duration, as well as 
subsequent reported energy levels and mood (Burkhart & Phelps, 2009). However, methods 
historically employed in studying sleep and mood are limited in that assessments are generally 
given once per day, and may not give a complete picture as to how well these interventions 
work. This introduction will describe the potential biological mechanisms of the link between 
mood and sleep related outcomes, describe the manipulated light intervention and the theory 
behind it, and will critique the historic sleep diary method of assessment, offering ecological 
momentary assessment (EMA) as an alternative.  
Mechanisms Common in Sleep Disturbance and Mood Disturbance 
The suprachiasmatic nucleus (SCN), located in the anterior portion of the hypothalamus, 
serves as the master pacemaker in humans. It is capable of oscillating rhythmically (in an 
approximate 24-hour pattern) without the presence of environmental cues, but it is influenced by 
external and internal environmental inputs (Zelinski et al., 2014). Such inputs can help the SCN 
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determine or interpret the time of day. Light, which arrives at the SCN from light-sensitive 
retinal ganglion cells expressing the photoreceptor melanopsin, exerts the strongest influence on 
the SCN, but neurotransmitters and hormones can also elicit effects on the SCN, as well as 
subsequent circadian rhythm and mood.  
For instance, the neurotransmitter serotonin is associated with both circadian rhythm and 
mood. Polymorphisms of serotonin transport genes have been linked with bipolar disorder and 
unipolar depression, and dysfunction of the serotonergic system contributes to current etiological 
theories of mood disorders (among others) (Harvey et al., 2011). The SCN contains a dense 
serotonergic plexus, denser than many other areas of the brain (Harvey et al., 2011). Serotonin 
acts on the SCN to enhance its overall stability in setting circadian rhythm, and the SCN also 
oversees the synthesis of serotonin into its derivative, melatonin (a circadian rhythm hormone) 
(Harvey et al., 2011).  Interestingly, lack of sleep and disruption in circadian rhythm can induce 
changes in the serotonergic system that are similar to those seen in unipolar depression, mainly 
that serotonin receptors become less sensitive to serotonin itself (Harvey et al., 2011).  
There is also a link between the circadian rhythm system and the dopaminergic system. 
The dopaminergic system, involved with reward activation, has been implicated in a wide variety 
of psychiatric disorders, including mood disorders. Changes in this pathway may help explain 
anhedonia in depressed patients, and its interaction with the serotonergic system is important for 
psychopathology of mood disorders (Harvey et al., 2011). Furthermore, reward activation and 
the dopaminergic system is moderated by circadian rhythm: mice that have a mutated Clock gene 
show increased dopamine activity and behaviors indicative of mania, including hyperactivity and 
decreased need for sleep (Harvey et al., 2011).  
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Interventions for Sleep and Mood Improvement 
For those who are struggling with mood or sleep problems, self-medication with alcohol 
or sleep medications is a relatively common option, but not an ideal one, as they can cause 
cognitive impairment, tolerance and dependence, and potential physical harm (Johnson, Roehrs, 
Roth, & Breslau, 1998; Rosenberg, 2006). Luckily, there are treatments for insomnia and mood 
symptoms that do not necessarily involve drugs or alcohol. Although it was previously described 
that sleep and circadian rhythm dysregulation are linked with serotonergic and dopaminergic 
functioning, in which dysfunction is usually treated with drugs, improvements in the 
neurobiology of the circadian system can be made non-pharmacologically (Harvey et al., 2011). 
For instance, Cognitive Behavioral Therapy for Insomnia (CBT-I) is generally effective in 
treating primary insomnia (Taylor & Pruiksma, 2014). Interpersonal and social rhythm therapy 
(Frank, 2007) and light therapy (Gottlieb & Terman, 2012) are also good candidates for 
improving sleep hygiene and mood symptoms. Social rhythm therapy involves maintaining 
stability in activity and social rhythms, and is shown to be effective in treating patients with 
bipolar disorder (Frank, 2007). Historically, bright light exposure has been used to treat patients 
with unipolar depression (with a seasonal pattern; Golden et al., 2005), and light restriction has 
been used for patients in a manic episode of bipolar disorder (Barbini et al., 2005). However, 
such treatments are not always feasible for patients, who would have to be willing to stay in 
complete darkness hours beyond when they would normally be asleep (Burkhart & Phelps, 
2009).  
 Another possible intervention strategy hinges on the fact that the photoreceptor 
melanopsin, which sends signals about light to the SCN, only responds to relatively short 
wavelengths of light (<550 nm), corresponding to the blue and blue-green portions of the visible 
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light spectrum (Burkhart & Phelps, 2009). Therefore, blue light has the strongest influence on 
signaling to the SCN and impacting circadian rhythm, as it signals for the SCN to suppress 
melatonin synthesis (Sasseville, Paquet, Sevigny, & Hebert, 2006). Theoretically, filtering out 
the blue wavelengths of light would essentially be the same as staying in complete darkness (as 
blocking the blue wavelengths of light would trigger the release of melatonin from the pineal 
gland), and could be a more feasible treatment than total darkness therapy (Sasseville et al., 
2006). Wearing amber-tinted glasses to filter out blue light emitted from artificial light sources in 
the evening would allow patients to participate in normal evening activities, rather than needing 
to stay in complete darkness. This type of intervention has been shown to improve sleep in 
patients with mood disorders, and in individuals who self-reported as having sleep difficulty 
(sleep-onset insomnia, mid-sleep insomnia, or terminal insomnia) (Henriksen et al., 2014; 
Burkhart & Phelps, 2009). Such glasses have also been shown to preserve high levels of 
melatonin production, similar to the level of melatonin produced in constant dim light (Kayumov 
et al., 2005). In studies investigating the effects of blocking blue light in the evening, participants 
were instructed to wear the glasses three hours before their target bedtime; after 2 weeks wearing 
the glasses, those in the amber glasses condition had significantly better self-reported sleep 
quality and significantly higher scores on a measure of positive affect, as compared to a control 
condition who wore yellow-tinted glasses that blocked ultra-violet light (Burkhart & Phelps, 
2009). Such an intervention is promising to treat sleep disturbances and mood problems, as the 
amber glasses pose little to no risk, are easily accessible, and are inexpensive.  
Using Ecological Momentary Assessment to Study Sleep and Mood 
 There are some drawbacks in the historic methodology of studying sleep and mood, 
however. For instance, many studies assessing interventions targeted to improve aspects of sleep 
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and affect rely on subjective measures of energy, mood, and sleep quality (Burkhart & Phelps, 
2009; Kayumov et al., 2005). These types of measures are limited in that participants may not be 
able to accurately self-identify and report on their energy levels or moods. Reporting in such a 
way may be especially difficult when using self-reported “sleep diaries,” in which participants 
code what time they went to bed, what time they woke up, their energy levels, and their 
perceived sleep quality. In the studies described above, participants were instructed to fill out the 
sleep diaries either the in the morning after they woke up (Burkhart & Phelps, 2009), or at night 
coding for the previous night’s sleep (Kayumov et al., 2005). In filling out the diaries this way, 
participants may not be able to accurately remember how they slept, or may realize that their 
energy levels changed throughout the day. Memories may be distorted, and the dynamic nature 
of energy and mood may not be best reflected in a single self-report measure or sleep diary for 
each day. 
 Ecological momentary assessment (EMA) may help combat these problems that arise 
when using sleep diaries or other self-report measures that rely on memory recall. EMA is a 
method for collecting data in real-time, and in a variety of conditions throughout a day (Miller, 
Kyle, Marshall, & Espie, 2013). It allows researchers to inquire about symptoms at the moment, 
rather than retrospectively, and in the environmental context in which they occur, which is 
beneficial when studying dynamic topics, such as energy levels and mood. EMA also employs 
frequent sampling, which when combined and analyzed together, can give a more complete 
assessment of symptoms throughout a single day and over longer spans of time (Levitt et al., 
2004).  
 A major benefit of using EMA is that it avoids the reliance on retrospective accounts of 
symptoms. Studies have shown that participants often overestimate positive emotions and 
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underestimate negative ones in a retrospective account, when compared to using EMA to assess 
emotions over a 24-hr period (Ebner-Priemer & Trull, 2009). Other cognitive biases can occur in 
retrospective accounts as well: due to an increased cognitive load resulting from thinking of 
symptoms over time, participants may be influenced by the personal heuristics effect (reporting 
experiences more personally relevant to their normal state), the salience or novelty effect 
(reporting experiences that seem unusual and stand out), or the mood-congruent memory effect 
(reporting experiences that are consistent with their current state and ignoring other experiences) 
(Trull & Ebner-Priemer, 2009). In contrast, EMA allows participants to answer questions about 
themselves without increasing cognitive load (i.e. “To what extent are you feeling fatigued right 
now?”), and therefore reduces potential recall biases (Trull & Ebner-Priemer, 2009).  
 EMA also allows researchers to assess the context in which certain symptoms occur. In 
many retrospective accounts, the focus is the symptom over a given amount of time (possibly 
over the past week, month, or year), but not in specific situations (e.g. while alone, while doing 
strenuous physical activities, while with others, while in stressful situations, etc.) (Ebner-Priemer 
& Trull, 2009). The potential interaction between the symptom and the context in which it occurs 
could provide valuable insight into the processes involved in the topic of study.  
 Another general advantage of using EMA over a retrospective measure of analysis is that 
EMA assesses symptoms in real-life situations, and can therefore be generalized to a greater 
extent (Ebner-Priemer & Trull, 2009). In theory, studying symptoms as they occur in their 
natural environment, rather than in a laboratory setting, can help researchers draw broader 
conclusions, and it helps raise external and ecological validity. However, it is important to note 
that there have not been any large-scale empirical studies that support the idea that an EMA 
design shows increased external validity over laboratory designs (Ebner-Priemer & Trull, 2009). 
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Future studies are needed to further evaluate the validity of data from projects using an EMA 
design (Ebner-Priemer & Trull, 2009). Furthermore, it is important to recognize that an 
inadequate or inappropriate research design (e.g. not choosing thoughtful items for EMA 
surveys/diaries or using a time sampling design that is not appropriate for your variables of 
interest) within an EMA study could threaten overall validity (Ebner-Priemer & Trull, 2009).  
The Present Study: Using EMA to Assess Response to Amber Glasses 
EMA has specific benefits in studying topics such as sleep/energy levels and mood, or in 
evaluating certain interventions, like the amber-tinted glasses. First of all, EMA can more readily 
assess dynamic processes and identify variability in symptoms more than a single retrospective 
account could. Moods and levels of daytime sleepiness are continuously expressed throughout 
the day, so they are subject to great levels of variability. Therefore, using an EMA approach with 
higher temporal resolution (i.e. taking measurements at multiple time points throughout the day) 
would be beneficial in order to get a sense of this variability (Ebner-Priemer & Trull, 2009).  
The present study used an EMA approach to more thoroughly assess the effectiveness of 
amber-tinted glasses targeted to improve sleep duration and quality, with sleep and mood-related 
measures taken at four time points each day. We hypothesized that, when wearing amber glasses, 
participants will report more improved overall sleep quality and mood (i.e. increased positive 
affect and decreased negative affect) than when wearing blue-lensed control glasses, as well as 
compared to baseline (no glasses). We also hypothesized that, when wearing amber glasses, 
participants will report lower energy earlier in the evening (corresponding to increased melatonin 
release) compared to wearing blue glasses or no glasses, as well as higher energy earlier in the 
morning (due to increased sleep quality) compared to wearing blue glasses or no glasses. We 
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hypothesized that these relationships would hold true, even when controlling for morning/ 
evening preference. 
Method 
Participants 
 39 participants from the University of North Carolina at Chapel Hill (students, staff, or 
faculty) were recruited through fliers and through online postings. These postings were targeted 
toward the general campus population, as well as toward a specific service organization. Those 
recruited from the service organization were offered their choice of 40 service hours or $40 as 
compensation upon completion of the study; general campus volunteers received $40 as 
compensation.  
Volunteers indicated their interest through email. Demographic information is listed in 
Table 1. Exclusion criteria included being younger than 18 years of age or older than 50 years of 
age, as well as not having a smartphone with text and email capabilities.  
Measures and Materials  
 Chronotype (i.e. Morningness-Eveningness Preference). The Student Morningness-
Eveningness Questionnaire (SMEQ) (Košćec, Radošević-Vidaček, & Kostović, 2001) assesses 
the time of day that participants experience peak alertness. The measure inquires about habits 
over a 24-hour period. Scores for each item range from 0 to 2, with lower scores indicating a 
preference for morning (or that one is a “morning person”) and higher scores indicating a 
preference for evening (or that one is a “night person”). The SMEQ has an internal consistency 
of .77 (Košćec et al., 2001). 
 State Affect. The Positive and Negative Affective Schedule (PANAS) (Watson, Clark, & 
Tellegen, 1988) was used to assess state affect throughout each day of the study. This measure is 
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made up of 20 items, 10 of which correspond to positive affect (e.g. “inspired,” “alert,”, 
“excited”) and 10 of which correspond to negative affect (e.g. “distressed,” “upset”, “irritable”). 
Participants rate the degree to which they feel that way at the moment from 1 (Very slightly or 
not at all) to 5 (Extremely). Higher scores indicate a higher level of positive affect or negative 
affect. The Cronbach's alpha is .90 for positive affect and .87 for negative affect (Watson et al., 
1988).  
 Sleepiness and Energy. The Stanford Sleepiness Scale (SSS) (Hoddes, Dement, & 
Zarcone, 1972) was included on the daily surveys and was used to assess present sleepiness. It is 
a one-item measure that uses a scale rating from 1 to 7 that corresponds to different degrees of 
sleepiness, with higher scores indicating a higher degree of sleepiness. Participants also 
responded to a separate question where they rated their present energy level on a scale from 0 
(Very low, exhausted) to 5 (Excellent energy).  
 Factors Affecting Sleep. Other EMA items. Other items were included on the daily 
surveys so that they could be used in lieu of single-time point, retrospectively assessed sleep 
diaries. Participants were asked if they had consumed caffeine since the previous survey (and if 
so, how much), if they had consumed alcohol since the previous survey (and if so, how much), if 
they had exercised since the previous survey (and if so, for how long), and if they had eaten since 
the previous survey (and if so, if it was a meal or a snack). The first survey of the day also asked 
participants to rate their sleep quality from the previous night on a scale from 1 (Very bad) to 5 
(Very good) and how many hours they slept. The first survey also asked participants what time 
they put on the glasses the previous night, if applicable.  
 Objective Measure of Sleep. GENEActiv accelerometer watches produced by 
ActivInsight Ltd. were used as an objective measure of sleep efficiency. These watches were 
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given to a random subset of participants, who wore them throughout the entire study on their 
non-dominant wrist. The GENEActiv watches are waterproof and non-intrusive (with 
dimensions of 43mm x 40mm x 13mm), making them suitable for continuous 24-hour wear. 
They measure skin temperature and produce a measure of sleep efficiency for each night of wear.  
 Colored Lenses. Participants wore Uvex Skyper Anti-Fog Safety Glasses with blue 
lenses (S1932X) and with amber lenses (S1933X) over the course of the study. Participants were 
randomized to starting color, and then switched to wearing the other color after 6 days. Figure 2 
shows the light transmittance of each type of glasses. We chose this particular model of glasses 
because the amber ones block a large percentage (>90%) of blue light from reaching the eye, 
larger than the percentage blocked from other models of amber glasses. We used blue glasses as 
control lenses to account for the potential placebo effect of simply wearing a pair of lenses. The 
blue color was chosen because it blocks a similar percentage of light from entering the eye, the 
opposite wavelengths than the amber ones do. Participants were asked to wear these glasses 
approximately three hours before their normal bedtime.  
Procedure 
 Participants responded to recruitment advertisements through email to schedule an in-
person meeting to review the consent form. Groups of participants were run in bursts over the 
course of four months to ensure there were sufficient materials available. Participants also 
completed a baseline SMEQ and a baseline demographics survey at this meeting.  
All participants began Day 1 of the study on a Saturday, to control for potential weekday/ 
weekend effects. For Days 1-6 of the study, participants completed baseline measures on the 
PANAS, the SSS, and the other sleep items on the EMA surveys. Four text messages (or emails, 
if the text messages did not work for the participants’ cell phone service provider) containing the 
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Qualtrics survey link were sent each day to the participants. The times of sending were 
randomized each day based on when participants reported waking up and falling asleep to ensure 
that the surveys would not be sent during a time they would likely be asleep. This study used 
signal contingent assessment, meaning that the participants were prompted to answer the survey 
questions when they got a new text/email alert to their phone. Participants were instructed to 
answer the surveys as soon as possible after receiving the message, provided that it was 
safe/appropriate to do so (i.e. not in class, driving, etc.).  
This study employed a randomized crossover design to assign glasses condition: in 
addition to answering the EMA surveys, participants were randomized to wear either amber or 
blue glasses for Days 7-12. Participants were instructed to wear these glasses three hours prior to 
their normal time of sleep onset. Nightly reminders were sent to all participants three hours 
before their reported bedtime to prompt them to put on the glasses. Participants returned to the 
lab before Day 13 to pick up their second pair of glasses. For Days 13-18, participants answered 
the EMA surveys and wore their second pair of glasses three hours before sleep onset. To 
measure adherence, participants were asked to email “selfies” of themselves wearing the glasses 
each night. These pictures were deleted immediately upon receipt.  
Some participants were also randomized to wear one of eight GENEActiv actigraphy 
watches, used as an objective measure of sleep quality. Participants were instructed to wear these 
watches on their non-dominant wrist for the entire study.  
After Day 18, participants returned all materials, were debriefed, and received their 
compensation. There was no penalty for missed surveys or for forgetting to wear the glasses.  
Results 
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Sample characteristics (gender, mean age, and race/ethnicity) are displayed in Table 1. 
One participant was excluded from analysis because of their irregular shift work schedule during 
the duration of the study. Additionally, two participants withdrew from participating in the study 
before its completion due to the time commitment it required. A total of 2692 surveys were sent 
out, and 2098 were answered, with a response rate of .80. A total of 15 participants were 
assigned to wear GENEActivs. Scores on all measures were converted to percent of maximum 
possible (POMP) scores. Table 2 shows the descriptive statistics for the PANAS, the SSS, the 
energy level item, the sleep quality item, the GENEActiv sleep efficiency estimate, and the 
SMEQ POMP scores.  
Mixed regression models were used to test all hypotheses, with repeated measures of 
sleep quality, energy, and affect nested within individuals. We ran models that allowed for 
random intercepts and random slopes. We tested for the color of glasses, the number of days in 
condition, time of day (morning versus non-morning survey), chronotype, and the interactions 
between glasses color * day in condition, day in condition *chronotype, glasses condition * 
chronotype, time of day * glasses condition, and time of day * chronotype. POMP scores for 
sleep quality, sleep efficiency, SSS, energy level, PA, and NA were used as outcome measures. 
Analyses were completed with the nlme package in R (Pinheiro et al., 2015). The crossover 
effect was assessed by adding ‘First Condition’ as a predictor in addition to the dichotomous 
condition variables; when it was included, the models were over fitted, so it was omitted. The 
following analyses lump participants’ first and second conditions together, with amber and blue 
conditions included as predictors, comparing outcomes to baseline as a reference.  
Sleep Quality 
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 The intercept of predicted sleep quality varied between participants, SD = .11, and the 
effect of the amber glasses condition also varied between participants over the course of the 
study, SD = .09, ICC = -.201. Figure 2 shows spaghetti plots of participants’ change in sleep 
quality by condition, where the varying slopes and intercepts are evident. Figure 3 shows a panel 
plot by glasses condition. We ran a model predicting sleep quality using the predictors described 
above. The beta weights are displayed in Table 3.  
 The intercept for the final model was significant, indicating that for the average person, 
sleep quality ratings were approximately 85% of the maximum possible at the start of the study 
(and significantly different from 0). While allowing slopes and intercepts to vary among 
individuals, both amber glasses condition and blue glasses condition significantly predicted sleep 
quality, predicting an 18% and 13% initial decrease in sleep quality compared to baseline, 
respectively. However, the significant interactions between amber condition and day in condition 
and blue condition and day in condition indicated that as day in each condition increased, the 
glasses condition improves participants’ sleep quality by an average of 2% and 3%, respectively. 
These interactions can be viewed graphically in Figures 4 and Figure 5. These show that sleep 
quality ratings increase up to baseline levels over the course of the condition wearing glasses 
(either color). This result is promising, but does not fully support the hypothesis that the amber 
glasses would increase overall sleep quality compared to baseline or blue glasses condition.   
We conducted similar models predicting sleep efficiency obtained from the GENEActiv 
watches that a subset of participants wore throughout the study. Sleep efficiency is the 
proportion of time one is asleep during a period of time they are in bed or trying to sleep. Here, 
we used it as more objective estimate of sleep quality. The sleep efficiency estimate was 
calculated through GENEActiv macro software.  
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Again, intercepts varied substantially across participants, SD = .12, as did the random 
effect of the amber glasses, SD = .16, ICC = -.787 (Figure 6, Figure 7). Beta weights are 
displayed in Table 4. The only significant portion of this model was the interaction between blue 
glasses condition and chronotype, with unit increase on the SMEQ (favoring more of an evening-
preference) associated with a .6% decrease in sleep quality while wearing the blue glasses, 
holding everything else constant. This interaction is depicted in Figure 8. Again, this did not 
support study hypotheses: there was not a significant main effect for amber glasses condition, 
and there were not significant interactions involving amber glasses condition, so the hypothesis 
that the amber glasses condition would improve sleep efficiency was not supported.  
Energy Level 
 Energy level was assessed using the Stanford Sleepiness Scale, and by a rating scale of 
energy from 0 – 5. The model for predicted scores on the SSS will be discussed first.  
 Again, intercepts for predicted sleepiness scores varied between participants at baseline, 
SD = .11. The effect of the amber glasses condition on energy level also varied between 
participants, SD = .04, ICC = .58 (Figure 9, Figure 10). Beta weights are displayed in Table 5. 
There was a significant main effect for blue glasses condition on energy level, with an average of 
a 9.62% increase in sleepiness during the blue glasses condition phase, holding all else constant. 
This is inconsistent with study hypotheses, as the blue glasses condition was the control lens and 
was not intended to change sleepiness levels. There was also a significant negative interaction 
between blue glasses condition and chronotype, with evening-preference associated with a 
weaker effect of the blue glasses on energy level. This is depicted in Figure 11. There was also a 
significant interaction between day in condition and amber glasses condition, meaning that as 
day in amber condition increased, the effect of the amber glasses on sleepiness got stronger. This 
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is depicted in Figure 12. The only other significant portion of the model was the interaction 
between day in condition and chronotype, meaning that over the course of each condition, having 
more of an evening-type had more of an influence on self-reported sleepiness. Overall, this 
model did not support study hypotheses.  
 We also examined predicted energy ratings. This model showed variation in intercepts, 
SD = .12, and in the random effect of the amber glasses, SD = .05, ICC = .26 (Figure 13, Figure 
14). Beta weights are shown in Table 6.  The intercept of this model was significant, indicating 
that the average person started out at 69.4% of the maximum score on energy at the start of the 
study. There were significant main effects for both the amber glasses and blue glasses conditions, 
with each being associated with an approximate 7% decrease in energy ratings. There was a 
significant positive interaction between the amber glasses condition and day in condition, 
though, with a 1.45% increase in the effect of the amber glasses on energy level for each 
additional day in that condition, ending with average energy ratings approaching baseline levels 
(Figure 15). This is a promising result, showing a linear increase of energy ratings over each day 
of wearing the amber glasses, but it still does not fully support the hypothesis that the amber 
glasses would improve overall energy levels. Furthermore, there was no significant interaction 
between amber glasses condition and morning versus evening survey, so the hypothesis that 
energy levels would be higher in the morning and lower in the evening during this condition was 
not supported.  
 There was a significant interaction between blue the blue glasses condition and 
chronotype, with unit increase toward evening-preference associated with a .59% increase in the 
effect of the blue glasses on energy level. Again, this does not support study hypotheses.  
Positive Affect 
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 There was variability in the intercepts across participants, SD = .12, and on the effect of 
the amber glasses on positive affect, SD = .05, ICC = -.04 (Figure 16, Figure 17). Beta weights 
for this model are displayed in Table 7. The intercept of this mixed model was significant, 
indicating that on average, participants started off the study responding at 40.95% of the 
maximum possible score for positive affect, holding all else constant. There were also significant 
main effects for both amber glasses condition and blue glasses condition, with each associated 
with an initial 11.51% and a 7.16% decrease in positive affect from baseline, respectively. There 
were significant positive interactions between each glasses condition and day in condition, 
though, meaning that participants’ scores on positive affect increased at a faster rate over the 
course of the time in each condition, eventually ending up with average positive affect scores 
similar to baseline levels at the end of each condition. These interactions are shown in Figures 18 
and 19. There was a significant general main effect for day in condition predicting positive 
affect, also associated with a decrease from baseline. Finally, there was as significant main effect 
for morning versus evening survey, with the morning survey being associated with higher 
positive affect scores compared to baseline, holding all else constant.  
Negative Affect 
 Finally, we examined models predicting negative affect. There was little variation in 
intercepts across participants, SD = .04, and in random effect of the glasses across participants, 
SD = .02, ICC = -.12 (Figure 20, Figure 21). Beta weights for this model are displayed in Table 
8. The intercept was significant for this model, indicating that on average, participants started the 
study at 3.61% of the maximum possible negative affect score. The only other significant 
portions in this model were the interactions between amber glasses condition and day in 
condition and between blue glasses condition and day in condition. Each was associated with a 
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steeper increase in negative affect scores as days continued in each condition (Figures 22 and 
23).  
Discussion 
 We hypothesized that the amber glasses condition would be associated with improved 
overall sleep quality (higher scores on self reported sleep quality and higher sleep efficiency 
estimates from the GENEActivs) and positive mood (increased positive affect on the PANAS), 
and decreased negative mood (lower scores on negative affect items on the PANAS). Most of the 
observed results do not support the first hypotheses: on some outcomes, the amber glasses 
condition did not have much of an impact, and on others both the experimental and control 
conditions showed an effect. Our second hypothesis that the amber glasses condition would be 
associated with higher energy levels in the morning and lower energy levels in the evening was 
not supported by study results. There was an unexpected main effect for time of day on positive 
affect ratings, however, irrespective of chronotype and glasses condition.  
 Overall, some portions of the results are promising, however: sleep quality and energy 
level increased over the course of wearing the amber glasses, but it is important to note that the 
effect occurred during the blue glasses condition as well for predicting sleep quality. This could 
have been due to placebo effect of wearing any pair of lenses, or perhaps the blue lenses had 
some sort of additional effect on sleep quality and energy ratings. Participants may have 
expected the blue lenses to cause a change on outcomes, or perhaps the flooding of blue light/ 
blocking of orange light at night causes some kind of unexpected physiological effect related to 
sleep quality and subsequent energy/mood. Use of another color of control lens would be 
beneficial in future studies. 
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 Perhaps the biggest limitation of this study is the lack of a washout period between 
glasses conditions: the effects of one glasses condition could have carried into the other 
condition, impacting results. Future studies could be conducted over a longer time period, 
allowing several days in between the glasses conditions. Other limitations include the large 
amount of females in the sample, and the lack of racial/ ethnic diversity. Larger, more diverse 
samples would be more beneficial. Furthermore, circadian rhythms fluctuate along the menstrual 
cycle (Baker & Driver, 2007), which could have caused differential responses in females, 
depending on their stage in the menstrual cycle at the time of the study. There were not strict 
exclusion criteria, as the researchers aimed to investigate the effects of the glasses in a broader, 
“real-world” sample, but this may have decreased internal validity and made confounding effects 
more likely. Another limitation includes the use of a non-clinical sample. There were 
floor/ceiling effects on some of the outcome measures (i.e. participants started the study with 
relatively high sleep quality and relatively low negative affect, for example), which could have 
made it less likely to detect changes in outcome that might have occurred. It also minimized the 
possible therapeutic effect of the glasses, if participants already scored well on the measures at 
baseline. Investigating the use of the glasses in a sample of individuals concerned with their 
sleep or mood at baseline would be a beneficial next step.  
It is important to note that these models only investigated the linear relationships between 
variables. Future analyses could investigate if there is a curvilinear effect of the glasses over time 
on these outcome measures. Other future studies could look at the possible moderating effects of 
race, gender, and age on responsiveness to the glasses. Furthermore, future studies could 
consider taking melatonin samples to measure physiological changes, and could study potential 
genetic differences between responders to the glasses and non-responders. Finally, parsing out 
EMA, AMBER GLASSES, SLEEP, & MOOD 
 
22 
weekend days versus weekdays could provide further insight in the future about how sleep 
quality, energy, and mood naturally change throughout the week, and how they might change 
differentially while wearing the glasses.  
To conclude, the study did not yield completely expected results and did not fully support 
our hypotheses that wearing amber-tinted glasses could improve sleep quality and mood and 
increase morning energy. However, these results do not completely rule out the possibility that 
these glasses could be an effective therapeutic tool to improve sleep and mood related outcomes. 
Future studies with a larger, more diverse sample, and more improved methodology could yield 
different results, which may one day help people with sleep or mood concerns.  
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Figure 1. Light transmittance for blue and amber lenses. Peak wavelength for melatonin 
suppression is ~446-477 nm.  
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Table 1.   
 
Sample Characteristics  
 Male (n) 
Female 
(n) 
Age 
(M) 
Age 
(SD) 
Caucasian 
(n) 
Asian 
American 
(n) 
African 
American 
(n) 
Hispanic (n) 
Overall 6 33 21.97 3.74 24 10 3 2 
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Table 2.  
Descriptive Statistics of Sleep Quality, GENEActiv Sleep Efficiency, 
SSS, Energy, and PANAS 
 N Mean SD Min Max 
Sleep Quality 
POMP 
566 .67 .24 0 1 
Sleep 
Efficiency 
POMP 
758 .71 .21 .05 1 
SSS POMP 
 
1996 .27 .24 0 1 
Energy POMP 1993 .64 .24 0 1 
Positive Affect 
POMP 
 
1955 .28 .19 0 .95 
Negative Affect 
POMP 
1960 .05 .08 0 .65 
 
Note: POMP = Percent of Maximum Possible; SSS = Stanford Sleepiness Scale; PANAS = 
Positive and Negative Affective Schedule 
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Figure 2. Spaghetti plot of linear trends within person for sleep quality (POMP), split by glasses 
condition 
  
EMA, AMBER GLASSES, SLEEP, & MOOD 
 
30 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Panel plot of individual data for sleep quality.   
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Table 3.  
 
Beta Weights for Model Predicting Self Reported Sleep Quality POMP Scores 
 
Predictor ß S.E. DF t p 
Intercept .85 .07 522 12.15 <.0001 
Amber condition (0,1) -.18 .07 522 -2.49 .01 
Blue condition (0, 1) -.13 .06 522 -2.12 .04 
Day in condition (0,6) -.02 .01 522 -1.21 .23 
SMEQ POMP -.01 .01 33 -1.81 .08 
Amber condition * day in 
condition 
.03 .01 522 2.50 .01 
Blue condition * day in 
condition 
.03 .01 522 2.27 .02 
Day in condition * SMEQ 
POMP 
-0.001 .001 522 -.81 .42 
Amber condition * SMEQ 
POMP 
.01 .01 522 1.61 .11 
Blue condition * SMEQ 
POMP 
.01 .004 522 1.16 .25 
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Figure 4. Interaction between amber condition (yes/no) and day in condition on sleep quality 
ratings.  
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Figure 5. Interaction between blue condition (yes/no) and day in condition on sleep quality 
ratings. 
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Figure 6. Spaghetti plot of linear trends within person for sleep efficiency (GENEActivs), split 
by glasses color.  
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Figure 7. Panel plot of individual data for sleep efficiency (GENEActivs).  
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Table 4. 
 
Beta Weights for Model Predicting GENEActiv Sleep Efficiency Estimate (POMP) 
 
Predictor ß S.E. DF t p 
Intercept .76 .08 738 10.08 <.0001 
Amber condition (0,1) -.02 .10 738 -.24 .81 
Blue condition (0, 1) .01 .04 738 .34 .74 
Day in condition (0,6) .003 .01 738 .36 .72 
SMEQ POMP -.01 .01 10 -.86 .41 
Amber condition * day in 
condition 
-.01 .01 738 -1.70 .09 
Blue condition * day in 
condition 
-.005 .01 738 -.54 .59 
Day in condition * SMEQ 
POMP 
.001 .001 738 1.71 .09 
Amber condition * SMEQ 
POMP 
.005 .01 738 .55 .58 
Blue condition * SMEQ 
POMP 
-.01 .002 738 -2.39 .02 
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Figure 8. Interaction between blue condition (yes/no) and chronotype on sleep efficiency 
estimate.  
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Figure 9. Spaghetti plot of linear trends within person for scores on Stanford Sleepiness Scale.  
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Figure 10. Panel plot of individual data for scores on the Stanford Sleepiness Scale 
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Table 5.  
 
Beta Weights for Model Predicting Stanford Sleepiness Scale POMP Scores 
Predictor ß S.E. DF t p 
Intercept .22 .05 1924 4.08 <.0001 
Amber condition (0,1) .07 .04 1924 1.94 .05 
Blue condition (0, 1) .10 .03 1924 2.91 .003 
Day in condition (0,6) -.01 .01 1924 -1.30 .19 
SMEQ POMP .003 .01 34 .54 .59 
Morning (1) vs. 
nonmorning (0) 
-.03 .03 1924 -1.15 .25 
Amber condition * 
morning 
-.02 .03 1924 -.97 .33 
Blue condition * morning -.05 .03 1924 -1.84 .07 
SMEQ POMP * morning .002 .002 1924 1.00 .32 
Amber condition * day in 
condition 
-.02 .01 1924 -2.23 .03 
Blue condition * day in 
condition 
-.005 .01 1924 -.69 .49 
Day in condition * SMEQ 
POMP 
.002 .001 1924 2.91 .004 
Amber condition * SMEQ 
POMP 
-.003 .003 1924 -.86 .39 
Blue condition * SMEQ 
POMP 
-.01 .003 1924 -2.42 .02 
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Figure 11. Interaction between blue condition (yes/no) and chronotype on ratings on the Stanford 
Sleepiness Scale. 
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Figure 12. Interaction between amber condition (yes/no) and day in condition on ratings on the 
Stanford Sleepiness Scale. 
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Figure 13. Spaghetti plot of linear trends within person for energy level, split by glasses color.  
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Figure 14. Panel plot of individual data for energy level.  
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Table 6.  
 
Beta Weights for Model Predicting Energy POMP Scores 
Predictor ß S.E. DF t p 
Intercept .69 .06 1921 12.49 <.0001 
Amber condition (0,1) -.09 .04 1921 -2.24 .03 
Blue condition (0, 1) -.07 .03 1921 -2.26 .02 
Day in condition (0,6) .003 .01 1921 .34 .74 
SMEQ POMP -.005 .01 34 -.93 .36 
Morning (1) vs. 
nonmorning (0) 
.04 .03 1921 1.56 .12 
Amber condition * 
morning 
.01 .03 1921 .59 .56 
Blue condition * morning .04 .03 1921 1.69 .09 
SMEQ POMP * morning -.003 .002 1921 -1.30 .19 
Amber condition * day in 
condition 
.01 .01 1921 2.18 .03 
Blue condition * day in 
condition 
.01 .01 1921 .76 .45 
Day in condition * SMEQ 
POMP 
-.001 .001 1921 -1.84 .07 
Amber condition * SMEQ 
POMP 
.01 .003 1921 1.60 .11 
Blue condition * SMEQ 
POMP 
.01 .003 1921 2.29 .02 
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Figure 15. Interaction between amber condition (yes/no) and day in condition on energy level 
ratings.  
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Figure 16. Spaghetti plot of linear trends within person for positive affect, split by glasses 
condition.  
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Figure 17. Panel plot of individual data for positive affect.  
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Table 7.  
 
Beta Weights for Model Predicting Positive Affect POMP Scores 
Predictor ß S.E. DF t p 
Intercept .41 .05 1883 7.71 <.0001 
Amber condition (0,1) -.12 .03 1883 -3.62 .0003 
Blue condition (0, 1) -.07 .02 1883 -3.02 .003 
Day in condition (0,6) -.02 .01 1883 -2.82 .005 
SMEQ POMP -.01 .005 34 -1.22 .23 
Morning (1) vs. 
nonmorning (0) 
.04 .02 1883 2.20 .03 
Amber condition * 
morning 
-.02 .02 1883 -1.34 .18 
Blue condition * morning .02 .02 1883 1.11 .27 
SMEQ POMP * morning -.002 .002 1883 -1.29 .20 
Amber condition * day in 
condition 
.02 .005 1883 4.89 <.0001 
Blue condition * day in 
condition 
.01 .005 1883 2.77 .01 
Day in condition * SMEQ 
POMP 
-.0002 .0004 1883 -.54 .59 
Amber condition * SMEQ 
POMP 
.002 .003 1883 .62 .53 
Blue condition * SMEQ 
POMP 
-.002 .002 1883 -1.12 .26 
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Figure 18. Interaction between amber condition (yes/no) and day in condition on positive affect 
ratings.  
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Figure 19. Interaction between blue condition (yes/no) and day in condition on positive affect 
ratings.  
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Figure 20. Spaghetti plot of linear trends within person for negative affect ratings, split by 
glasses condition.  
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Figure 21. Panel plot of individual data for negative affect ratings.  
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Table 8.  
 
Beta Weights for Model Predicting Negative Affect POMP Scores 
Predictor ß S.E. DF t p 
Intercept .04 .02 1889 2.05 .04 
Amber condition (0,1) -.01 .01 1889 -.72 .47 
Blue condition (0, 1) -.01 .01 1889 -.90 .37 
Day in condition (0,6) -.002 .002 1889 -.63 .53 
SMEQ POMP .002 .002 34 .98 .33 
Morning (1) vs. 
nonmorning (0) 
.005 .009 1889 .50 .61 
Amber condition * 
morning 
-.009 .008 1889 -1.06 .29 
Blue condition * morning -.009 .008 1889 -1.10 .27 
SMEQ POMP * morning -0.00004 .0007 1889 -.06 .95 
Amber condition * day in 
condition 
.005 .002 1889 2.56 .01 
Blue condition * day in 
condition 
.005 .002 1889 2.45 .01 
Day in condition * SMEQ 
POMP 
.0001 .0002 1889 .55 .59 
Amber condition * SMEQ 
POMP 
.0003 .001 1889 .27 .79 
Blue condition * SMEQ 
POMP 
.0002 .001 1889 .23 .82 
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Figure 22. Interaction between amber condition (yes/no) and day in condition on negative affect 
ratings.  
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Figure 23. Interaction between blue condition (yes/no) and day in condition on negative affect 
ratings.  
